Saturday, August 21, 2021 9:55:56 AM
I wonder how many of the shares here are currently short? Will they cover when the final Q is submitted? They can't expect this price to hold or reduce when that happens. This could very well go on an ENZ* run in weeks afterwards. Could even surpass that one with real hype of a buyout. What will they do?
All information provided is the opinion of this poster from review of information in the public domain.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
